JPH01172338A - Preventive and remedy for swine dysentery - Google Patents
Preventive and remedy for swine dysenteryInfo
- Publication number
- JPH01172338A JPH01172338A JP62328327A JP32832787A JPH01172338A JP H01172338 A JPH01172338 A JP H01172338A JP 62328327 A JP62328327 A JP 62328327A JP 32832787 A JP32832787 A JP 32832787A JP H01172338 A JPH01172338 A JP H01172338A
- Authority
- JP
- Japan
- Prior art keywords
- crude drug
- scutellariae
- rhizome
- root
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000282898 Sus scrofa Species 0.000 title claims description 22
- 208000001848 dysentery Diseases 0.000 title claims description 22
- 230000003449 preventive effect Effects 0.000 title abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 41
- 229940079593 drug Drugs 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003960 organic solvent Substances 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 241000411851 herbal medicine Species 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 16
- 229940124597 therapeutic agent Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 10
- 229940010454 licorice Drugs 0.000 claims description 10
- 235000011399 aloe vera Nutrition 0.000 claims description 9
- 230000000069 prophylactic effect Effects 0.000 claims description 9
- 241001116389 Aloe Species 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 7
- 240000005528 Arctium lappa Species 0.000 claims description 3
- 235000003130 Arctium lappa Nutrition 0.000 claims description 3
- 235000008078 Arctium minus Nutrition 0.000 claims description 3
- 241000219793 Trifolium Species 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 241000283690 Bos taurus Species 0.000 abstract description 4
- 244000184734 Pyrus japonica Species 0.000 abstract description 4
- 240000007474 Aloe arborescens Species 0.000 abstract description 2
- 235000004509 Aloe arborescens Nutrition 0.000 abstract description 2
- 241001183967 Isodon Species 0.000 abstract description 2
- 244000132436 Myrica rubra Species 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 241000218203 Coptis japonica Species 0.000 abstract 2
- 235000008375 Decussocarpus nagi Nutrition 0.000 abstract 1
- 244000144994 Galla Rhois Species 0.000 abstract 1
- 235000014631 Myrica rubra Nutrition 0.000 abstract 1
- 241000282887 Suidae Species 0.000 description 17
- 238000012360 testing method Methods 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 240000004670 Glycyrrhiza echinata Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- -1 n -Propertool Chemical compound 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 241001124076 Aphididae Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010022678 Intestinal infections Diseases 0.000 description 2
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000207929 Scutellaria Species 0.000 description 2
- 241000589886 Treponema Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000007799 cork Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001365032 Isodon trichocarpus Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 241000721570 Melaphis Species 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 241000275031 Nica Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- DCYOADKBABEMIQ-OWMUPTOHSA-N myricitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=C(O)C=2)OC2=CC(O)=CC(O)=C2C1=O DCYOADKBABEMIQ-OWMUPTOHSA-N 0.000 description 1
- DCYOADKBABEMIQ-FLCVNNLFSA-N myricitrin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2cc(O)c(O)c(O)c2)Oc2c(c(O)cc(O)c2)C1=O DCYOADKBABEMIQ-FLCVNNLFSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は豚赤痢の予防及び治療剤並びに予防及び治療方
法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a prophylactic and therapeutic agent and a prophylactic and therapeutic method for swine dysentery.
さらに詳しくは、本発明は細菌Treponeiahy
odysenLeriaeによる豚の感染症である豚赤
痢の生薬を用いる予防及び治療剤並びに予防及び治療方
法に関する。More specifically, the present invention relates to the bacterium Treponeiahy.
The present invention relates to preventive and therapeutic agents and preventive and therapeutic methods using crude drugs for swine dysentery, which is an infectious disease of pigs caused by P. odysen Leriae.
[従来の技術]
豚赤痢とは、豚の細菌性伝染病の1つであって、病原体
はTreponeia hyodysenterlae
である。豚の発育遅延、飼料効率の低下などをもたらし
、また−度発生すると常在化する傾向があるため、養豚
業に与える産業的被害も大きく、豚の数ある疾病の中で
もその防除対策の確立が急がれる最も重要疾病の1つで
ある。[Prior Art] Swine dysentery is one of the bacterial infectious diseases of pigs, and the pathogen is Treponeia hyodysenterlae.
It is. It causes delayed growth of pigs, reduced feed efficiency, etc., and tends to become endemic when it occurs, causing great industrial damage to the pig farming industry, and among the many diseases of pigs, it is difficult to establish control measures. It is one of the most urgent diseases.
本疾病は粘血下痢便の排泄を主機とする急性または慢性
の腸管感染症である。罹患側は赤痢症状を呈し、死亡率
は約5〜25%である。慢性化したものは一般に予後不
良で、死亡を免れても発育が停止してしまう。This disease is an acute or chronic intestinal infection mainly caused by the excretion of mucus and bloody diarrhea. The affected side exhibits symptoms of dysentery, and the mortality rate is approximately 5-25%. Chronic cases generally have a poor prognosis, and even if death is avoided, growth stops.
このような重大な伝染病であるにもかかわらず、有効な
対策は殆んどなく、適切な飼育管理を行なうことなどが
とられているが、実際には予防できないことが多い。Despite the fact that it is such a serious infectious disease, there are almost no effective countermeasures, and although measures such as proper breeding management are taken, in reality, it is often impossible to prevent it.
また、これまでに本疾病を予防及び治療するために、例
えば抗生物質やその他の抗菌剤を飼料と共に投与する方
法も行なわれている。しかし、近年特に耐性菌の発生や
動物への抗生物質等の残留性の問題などがあって、抗生
物質などの投与を家畜等の動物に対して行なうことは適
当でないという気運が高まりつつある。従って、抗生物
質などを用いない本庁の予防及び治療方法と予防及び治
療剤の開発が望まれている。Furthermore, in order to prevent and treat this disease, for example, methods have been used in which antibiotics and other antibacterial agents are administered together with feed. However, in recent years, there has been a growing trend that it is not appropriate to administer antibiotics to animals such as livestock due to problems such as the emergence of resistant bacteria and the persistence of antibiotics in animals. Therefore, the development of preventive and therapeutic methods and preventive and therapeutic agents that do not use antibiotics is desired.
[問題点を解決するための手段]
本発明者らは、上記の問題点を解決すべく研究した結果
、ある種の生薬に本疾病を抑制する効果がある事を見出
し、本発明を完成させた。[Means for Solving the Problems] As a result of research to solve the above problems, the present inventors discovered that certain herbal medicines have the effect of suppressing this disease, and completed the present invention. Ta.
即ち、本発明の目的は、豚赤痢の予防及び治療剤並びに
同庁の予防及び治療方法を提供することにある。That is, an object of the present invention is to provide a preventive and therapeutic agent for swine dysentery and a method for preventing and treating swine dysentery.
本発明は、カンゾウ、オウレン、オウゴン、ヨウバイヒ
、アロエ、ギュウタン、エンメイソウ及びゴバイシから
なる群から選択された1種または2種以上の生薬を含有
する豚赤痢の予防及び治療剤を提供するものである。The present invention provides a prophylactic and therapeutic agent for swine dysentery containing one or more herbal medicines selected from the group consisting of licorice, scutellariae, scutellariae, scutellariae, aloe, gyutan, chilifolia, and burdock. .
本発明はまた原末の形態の生薬、有機溶剤、有機溶剤と
水との混合物または水で抽出して得られる生薬エキス、
または生薬有効成分を含有する上記の豚赤痢の予防及び
治療剤を提供するものである。The present invention also relates to crude drugs in the form of bulk powders, organic solvents, mixtures of organic solvents and water, or crude drug extracts obtained by extraction with water;
Alternatively, the present invention provides the above-mentioned preventive and therapeutic agent for swine dysentery containing an active ingredient of herbal medicine.
更に本発明は、カンゾウ、オウレン、オウゴン、ヨウバ
イヒ、アロエ、ギュウタン、エンメイソウ及びゴバイシ
からなる群から選択された1種または2種以上の生薬の
有効量を投与することからなる豚赤痢の予防及び治療方
法を提供するものである。Furthermore, the present invention provides a method for the prevention and treatment of swine dysentery, which comprises administering an effective amount of one or more crude drugs selected from the group consisting of licorice, orensis, scutellariae, scutellariae, aloe, gyutan, chiliflower, and burdock. The present invention provides a method.
本発明はまた、原末の形態の生薬、有機溶剤、有機溶剤
と水との混合物または水で抽出して得られる生薬エキス
、または生薬有効成分の形態で投与することからなる豚
赤痢の予防及び治療方法を提供するものである。The present invention also relates to the prevention and treatment of swine dysentery, which comprises administering crude drugs in the form of bulk powders, organic solvents, mixtures of organic solvents and water, crude drug extracts obtained by extraction with water, or active ingredients of crude drugs. It provides a treatment method.
本発明はまた、生薬を飼料中に配合して投与することか
らなる豚赤痢の予防及び治療方法を提供するものである
。The present invention also provides a method for preventing and treating swine dysentery, which comprises administering a crude drug in feed.
カンゾウ(甘草)は、カンゾウ(Glyeyrrhlz
aglabra LInnA var、 gland
ulifera Regel etHerder)の根
及び根茎をそのまま、またはコルク皮を除いたものであ
る。このものは成分としてグリシルリチン、リキリチン
、ブドウ糖、アスパラギン等を含み、ヒトの緩和、鎮痙
薬、袂痰薬として用いられている。Licorice (licorice) is called daylily (Glyeyrrhlz)
aglabra LInnA var, grand
ulifera Regel et Herder) roots and rhizomes as they are or with the cork skin removed. This product contains ingredients such as glycyrrhizin, liquiritin, glucose, and asparagine, and is used as a relaxing, antispasmodic, and phlegm medicine for humans.
オウレン(黄連)は、オウレン(Coptisjapo
nica Makino)の根茎から細根を焼去ったも
のである。このものは成分としてベルベリン、パルマチ
ン等を含み、ヒトの健胃苦味、整腸薬として用いられて
いる。Ouren (Yellow Ren) is ouren (Coptisjapo).
It is made by burning off the fine roots from the rhizomes of Nica Makino. This product contains ingredients such as berberine and palmatine, and is used as a bitter and intestinal medicine for humans.
オウゴン(i29)は、コガネバナ(Scutel I
arlabalcalensis Georgl)のコ
ルク皮を除いた根である。このものは成分として、オー
ゴニンとパイカリンを含み、ヒトの消炎、解熱薬として
用いられている。Scutel I (i29) is Scutel I
This is the root of the plant (Arlabalcalensis Georgl) with the cork skin removed. This product contains orgonin and picalin as ingredients, and is used as an anti-inflammatory and antipyretic drug for humans.
ヨウバイヒ(揚梅皮)は、ヤマモモ(Myrlcaru
bra 5iebold at Zuccarini)
の樹皮である。このものは成分としてタンニン、ミリセ
チン及びミリシトリン等を含みヒトの収れん薬として下
痢に用い、また打撲症に効果がある。Youbaihi (fried plum skin) is a Japanese bayberry (Myrlcaru).
bra 5iebold at Zuccarini)
It is the bark of the tree. This product contains tannins, myricetin, myricitrin, etc., and is used as an astringent for diarrhea in humans, and is also effective against bruises.
アロエは、アロエ(Aloe arborescens
Mill。Aloe is Aloe arborescens.
Mill.
var、 raLalensis Bergel、)の
粘液を煮つめたものである。このものは成分として、バ
ルバロイン、アロエーエモジン等を含み、中東やヨーロ
ッパで、非常に古くからヒトの苦味健胃薬または下剤と
して用いられている。var, raLalensis Bergel,). This product contains barbaloin, aloe emodin, etc. as ingredients, and has been used as a bitter stomachic or laxative for humans in the Middle East and Europe since ancient times.
ギュウタン(牛脂)は、ウシ(Bos taurusd
omesLIcus GIlelln)の胆のうをぶら
下げて陰干しするか、または胆管を切開して胆汁を容器
に入れて密封貯蔵したものである。このものは成分とし
てコール酸ナトリウム塩、ムコタンパク質、脂肪酸等を
含み、ヒトの黄庭、便秘、糖尿病、痔癒等の治療に古く
から用いられている。Gyutan (beef tallow) is derived from cow (Bos taurus).
The gallbladder of the omes LIcus GIlelln) is hung to dry in the shade, or the bile duct is incised and the bile is stored in a container in a sealed container. This product contains sodium cholate, mucoprotein, fatty acids, etc. as ingredients, and has been used for a long time to treat conditions such as jaundice, constipation, diabetes, and hemorrhoid healing in humans.
エンメイソウ(延命草)は、ヒキオコシ(Isodon
japonica Hara)またはクロバナヒキオ
コシ(Isodon trichocarpus Ku
do)の茎葉である。Enmeiso (Enmeiso) is called Hikiokoshi (Isodon).
japonica Hara) or Isodon trichocarpus Ku
These are the stems and leaves of do).
このものは成分として、プレクトランチン及びエンメイ
ンを含み、ヒトの健胃苦味薬として消化不良、食欲不振
、腹痛等の治療に用いられる。This product contains plectrantin and enmain as ingredients, and is used as a bitter medicine for human stomach health to treat indigestion, anorexia, abdominal pain, etc.
ゴバイシ(五倍子)は、ヌルデノミミフシアブラムシ(
Melaphis chlnensls J、 Be1
l)の刺傷により主としてヌルデ(Rhus java
nica L[nnj )の葉に生じたゴールであって
、成分としてタンニン、没食子酸、脂肪、樹脂等を含む
。五倍子チンキ、タンニン酸、没食子酸、ピロガロール
の製造原料とされる。Gobaishi (Gobaishi) is the aphid (Nurudenomimifushia aphid)
Melaphis chlnensls J, Be1
The sting of Rhus java
It is a gall produced in the leaves of nica L [nnj), and contains tannin, gallic acid, fat, resin, etc. as components. It is used as a raw material for the production of five-fold tincture, tannic acid, gallic acid, and pyrogallol.
上記したように、本発明で用いる生薬のカンゾウ、オウ
レン、オウゴン、ヨウバイヒ、アロエ、ギュウタン、エ
ンメイソウ及びゴバイシの夫々は、それらを単独でか、
または組合わせてヒトの疾病の予防及び治療のために従
来から使用されていたものであるがこれらを豚の疾病の
予防及び治療の目的、殊に豚の感染症の予防及び治療の
目的で使用する試みはこれまでになされたことがなかっ
た。As mentioned above, each of the herbal medicines used in the present invention, such as licorice, orensis, scutellariae, scutellariae, aloe, gyutan, japonica, and gobaishi, can be used alone or
or in combination with products that have traditionally been used for the prevention and treatment of human diseases, but these are used for the purpose of preventing and treating diseases in pigs, especially for the purpose of preventing and treating infectious diseases in pigs. No attempt had ever been made to do so.
本発明者らは上記した生薬の薬効に着目して種々研究を
行なった結果、豚赤痢、即ち豚が細菌のTrepone
ma hyodyscntcriaeに腸管感染するこ
とによって発生する疾病の予防及び治療に上記した生薬
の1種または2種以上を組合わせて投与することがきわ
めて有効であることを見出し、本発明を完成したのであ
る。The present inventors have conducted various studies focusing on the medicinal effects of the above-mentioned herbal medicines, and have found that swine dysentery, that is, pigs are affected by the bacterium Trepone.
The present invention was completed based on the discovery that administering one or more of the above-mentioned herbal medicines in combination is extremely effective for the prevention and treatment of diseases caused by intestinal infection with M. ma hyodyscntcriae.
即ち、下記するように、上記した特定の種類の生薬及び
その抽出物が、インビトロ及びインビボにおいて細菌T
reponesa hyodysentertaeに対
し特異的に静菌作用及び殺菌作用があることが明らかに
なった◎そしてこのTrepOnella hyody
senterlaeに対する抑制効果の結果、上記した
生薬を豚に投与した場合に、Treponema hy
odysenterlae に由来する豚の疾病である
豚赤痢を予防及び治癒することができたのである。That is, as described below, the above-mentioned specific types of herbal medicines and their extracts are effective against bacterial T.
It has been revealed that TrepOnella hyodysentertae has bacteriostatic and bactericidal effects specifically against TrepOnella hyodysentertae.
As a result of the inhibitory effect on Treponema hy.
It was possible to prevent and cure swine dysentery, a disease of pigs caused by P. odysenterlae.
そしてこの豚に特有の疾病に対して上記した特定の生薬
及びその抽出物が有効であることは予想もしえなかった
ことで、本発明者らによってはじめて明らかにされたこ
とである。The effectiveness of the above-mentioned specific herbal medicines and their extracts against this disease unique to pigs was unexpected and was revealed for the first time by the present inventors.
これら生薬は原末そのまま、または抽出エキス、生薬有
効成分の形態で直接投与したり、またこれらのものを飼
料に添加したりあるいは溶液製剤、分散製剤、半固形製
剤、粉粒体製剤、成型製剤、浸出製剤、注射用製剤等に
製剤化して使用する。These crude drugs can be administered directly in the form of raw powder, extracts, or active ingredients of crude drugs, or they can be added to feed, or solutions, dispersions, semi-solids, powders, and molded preparations. It is used in formulations such as infusion preparations, injection preparations, etc.
抽出エキスは、例えば水、有機溶剤または水と有機溶剤
との混合物を使用して溶剤抽出し、それをそのままか、
濃縮してか、希釈してか、または溶剤を除去して用いら
れる。Extracts can be obtained by solvent extraction, for example using water, an organic solvent, or a mixture of water and an organic solvent, and then left as is, or
It can be used concentrated, diluted, or with the solvent removed.
有機溶剤としては、例えばメタノール、エタノール、n
−プロパツール、n−ブタノール、アセトン、酢酸エチ
ル、エーテル、塩化メチレン、クロロホルム、ベンゼン
、四塩化炭素、石油エーテル等が使用され、特にメタノ
ール、エタノールが望ましい。これらの有機溶剤は1種
または2種以上の混合物として用いることができる。Examples of organic solvents include methanol, ethanol, n
-Propertool, n-butanol, acetone, ethyl acetate, ether, methylene chloride, chloroform, benzene, carbon tetrachloride, petroleum ether, etc. are used, and methanol and ethanol are particularly preferred. These organic solvents can be used alone or as a mixture of two or more.
この溶剤抽出は、生薬をこれらの溶剤に冷浸または温浸
して行なうことができる。冷浸の場合には15〜25℃
、温浸の場合は35〜45℃の温度範囲で行なうことが
できる。抽出時間は、抽出温度によって異なるが、−殻
内には約5日間または可溶性成分が充分に溶けるまでと
する。This solvent extraction can be carried out by cold soaking or digesting the herbal medicine in these solvents. 15-25℃ for cold soaking
Digestion can be carried out at a temperature range of 35-45°C. The extraction time will vary depending on the extraction temperature, but may be approximately 5 days or until the soluble components are fully dissolved in the shell.
生薬有効成分は、例えば、上記抽出エキスをさらに各種
溶剤を用いて振盪し、この溶剤に移行する両分を採り出
し、その溶剤を留去したものを有効画分、即ち白゛効成
分として用いることもできる。The active ingredients of herbal medicine can be obtained by, for example, shaking the above-mentioned extract using various solvents, extracting the fraction that transfers to the solvent, and distilling off the solvent, which is used as the effective fraction, that is, the white active ingredient. You can also do that.
この場合に使用される溶剤は、非極性溶剤例えば、低級
脂肪族エーテル類(ジエチルエーテル、エチルメチルエ
ーテル等);低級ハロゲンアルカン類(クロロホルム、
ジクロルエタン、ジブロモエタン等);ベンゼン類(ベ
ンゼン、トルエン、キシレン等);その他の石油系溶剤
(石油エーテル、石油ベンゼン、リグロイン等)等が例
としてあげられる。Solvents used in this case include nonpolar solvents such as lower aliphatic ethers (diethyl ether, ethyl methyl ether, etc.); lower halogen alkanes (chloroform, ethyl methyl ether, etc.);
Examples include dichloroethane, dibromoethane, etc.); benzenes (benzene, toluene, xylene, etc.); and other petroleum solvents (petroleum ether, petroleum benzene, ligroin, etc.).
また、この有効画分を採り出した残りの水溶液を、水及
びある種の有機溶剤に水を飽和させたものを使用するこ
とにより振盪抽出し、水洗し、残分である有機溶剤層に
移行する両分の溶剤を留去したものも、有効画分即ち有
効成分として用いることができる。この有効画分は上記
の有効画分とは、物理化学的性質が異なり、検出される
成分も異なるものである。In addition, the remaining aqueous solution from which this effective fraction was extracted is extracted by shaking using water and a kind of organic solvent saturated with water, washed with water, and transferred to the organic solvent layer that is the residue. A product obtained by distilling off both solvents can also be used as an effective fraction, that is, as an active ingredient. This effective fraction has different physicochemical properties and different detected components from the above-mentioned effective fraction.
投与量は、生薬の原末重量で換算して0.001mg/
体ffi)cg/日〜100./体重kg/日の範囲で
ある。The dose is 0.001mg/converted to the weight of the raw drug powder.
body ffi) cg/day ~ 100. /kg body weight/day.
この量は予防剤として用いる場合と治療剤として用いる
場合では異なり、−殻内には後者の方が投与量は多くな
る。This amount is different when used as a prophylactic agent and when used as a therapeutic agent - the dose in the shell is higher in the latter case.
投与方法は、経口投与または非経口投与することができ
、非経口投与としては筋肉内投与、腹腔内投与、経皮投
与、経鼻投与、静脈内投与等が可能である。The administration method can be oral or parenteral administration, and examples of parenteral administration include intramuscular administration, intraperitoneal administration, transdermal administration, nasal administration, intravenous administration, and the like.
[発明の効果]
以上詳述したように、本発明によれば豚赤痢の有効な予
防及び治療剤並びに有効な予防及び治療方法が提供され
る。[Effects of the Invention] As detailed above, the present invention provides an effective preventive and therapeutic agent and an effective preventive and therapeutic method for swine dysentery.
本発明の予防及び治療剤は生薬またはそれから得られる
エキス等を生薬とするため、抗生物質等の場合の耐性菌
の発生や副作用の問題が全くなく、安心して投与するこ
とができる。Since the prophylactic and therapeutic agent of the present invention uses herbal medicines or extracts obtained from them as herbal medicines, there is no problem of the development of resistant bacteria or side effects associated with antibiotics, etc., and it can be administered with confidence.
また、薬剤の残留による人体への影響の心配がないため
、肉用豚に対する豚赤痢の予防及び治療のための薬物と
して適当である。Furthermore, since there is no concern about the effects of drug residue on the human body, it is suitable as a drug for preventing and treating swine dysentery in meat pigs.
さらに、抗生物質等を用いる場合に比べて、安価に同疾
病を予防及び治療することができる。Furthermore, the disease can be prevented and treated at a lower cost than when using antibiotics or the like.
以下本発明を試験例及び実施例により更に詳しく説明す
る。The present invention will be explained in more detail below using test examples and examples.
試験例 I
Treponesa ]+yodysenterjae
の各種生薬に対する感受性を調べた。Test Example I Treponesa] + yodysenterjae
The susceptibility to various herbal medicines was investigated.
各種生薬を、生薬に対し7倍量の50%エタノール水溶
液中に加え、16時間抽出してアルコール抽出してアル
コール抽出物とした。Various crude drugs were added to a 50% ethanol aqueous solution in an amount seven times the amount of the crude drug, extracted for 16 hours, and then extracted with alcohol to obtain an alcohol extract.
抽出物を直径8龍のディスクに25μIずつしみ込ませ
乾燥させた。このディスクを上記Treponema
hyodysenterlaeの菌株を塗った血液寒天
培地に置き、37℃で18時間培養した後の阻止円の直
径を測定した。The extract was infiltrated into a disk with a diameter of 8 mm at a dose of 25 μl and dried. Transfer this disk to the above Treponema
hyodysenterlae strain was placed on a blood agar medium and cultured at 37° C. for 18 hours, the diameter of the inhibition circle was measured.
次にその試験結果を示せば表1のとおりである。Next, the test results are shown in Table 1.
(以下余白)
表 1
カンゾウ 20
オ ウ し ン 32オウゴ
ン 14
ヨ、ウバイヒ 9
ア ロ エ 32ギユウ
タン 20
エンメイソウ 15
ゴバイシ 13
実施例 1
基礎飼料
とうもろこし 450重量部
マ イ ロ
31O〃大 豆 粕
146//な た ね 粕
30 〃魚 粉
15・・肉 骨 粉
10ffi量部イエローグリス 1g
”炭酸カルシウム 5 〃
りん酸カルシウム 8 〃食
塩 3 〃プレミックス
5 〃
前記基礎飼料にオウレン粉末を重量比で2%添加し供試
飼料とした。(Leaving space below) Table 1 Licorice 20 Corn 32 Scutellariae 14 Yo-Ubaihi 9 Aloe 32 Gyutan 20 Chillies 15 Gobaishi 13 Example 1 Basic feed corn 450 parts by weight Milo
31O soybean meal
146//Na Ta Ne Kasu
30 Fish powder
15. Meat bone powder
10ffi yellow grease 1g
” Calcium carbonate 5 Calcium phosphate 8 Food
Salt 3 Premix 5 2% by weight of Oren powder was added to the basic feed to prepare a test feed.
60日令の健康な豚100頭に前記供試飼料を自由摂餌
させ180日令まで飼育し、その期間中に野外感染での
豚赤痢による下痢をした頭数及びその日数を観察した。100 healthy pigs, 60 days old, were fed the test feed ad libitum until they were 180 days old, and during this period, the number of pigs suffering from diarrhea due to field infection and the number of days were observed.
なお対照区は前記供試飼料に代えて基礎飼料を与えた以
外は前記と同様に行なった。The control group was treated in the same manner as above except that basal feed was given instead of the test feed.
その結果試験区は豚赤痢による下痢をした豚は2頭/1
00頭であり、下痢をした延べ日数は8日/ 1200
0日であるのに対し、対照区では豚赤痢による下痢をし
た豚は36頭/100頭であり、下痢をした延ベロ数は
221日/ 12000日であった。As a result, in the test area, the number of pigs with diarrhea due to swine dysentery was 2/1.
00 cows, and the total number of days with diarrhea was 8 days / 1200.
In contrast, in the control area, 36/100 pigs had diarrhea due to swine dysentery, and the total number of pigs with diarrhea was 221/12,000 days.
実施例 2〜8
実施例1においてオウレンの代わりに、カンゾウ、オウ
ゴン、ヨウバイヒ、アロエ、ギュウタン、エンメイソウ
及びゴバイシを夫々基礎飼料に1%添加し、供試飼料と
した以外は実施例1と同様に行なった。Examples 2 to 8 The same procedure as in Example 1 was carried out except that instead of Oren in Example 1, 1% of each of Licorice, Scutellariae, Scutellariae, Aloe, Gyutan, Trifolium, and Cucumber were added to the basal feed at 1% and used as the test feed. I did it.
次にその試験結果を示せば表2のとおりである。Next, the test results are shown in Table 2.
(以下余白)
実施例 9
カンゾウ、オウレン、オウゴン、ヨウバイヒ、アロエ、
ギュウタン、エンメイソウ、ゴバイシの各々を1kgと
りこれを夫々10gの水に入れ100’Cで1時間抽出
した。各々の水抽出物を1000倍に希釈し抽出エキス
とした。(Left below) Example 9 Licorice, Oriental lily, Scutellaria japonica, Scutellaria sinensis, Aloe vera,
1 kg of each of Gyutan, Enmeisou, and Gobaishi was taken, added to 10 g of water, and extracted at 100'C for 1 hour. Each water extract was diluted 1000 times to obtain an extract.
60日令の豚を100頭ずつ使用し試験区は抽出エキス
を水の代わりに給与し100日令まで飼育した。100 60-day-old pigs were used in each test group, and the extract was fed in place of water, and the pigs were kept until they were 100 days old.
なお飼料は実施例1で使用した基礎飼料を用いた。Note that the basal feed used in Example 1 was used as the feed.
対照区は前記抽出エキスの代わりに水のみを給与した。The control group received only water instead of the extract.
次に試験期間中における野外感染での豚赤痢による下痢
の頭数及び下痢をした日数を観察した。その結果試験区
は対照区に比べて豚赤痢による野外感染による下痢の頭
数は少なく、その延べ日数も少なかった。Next, during the test period, the number of animals with diarrhea due to swine dysentery and the number of days with diarrhea during field infection were observed. As a result, the number of animals suffering from diarrhea due to field infection due to swine dysentery was smaller in the test plot than in the control plot, and the total number of days of diarrhea was also smaller.
Claims (1)
エ、ギュウタン、エンメイソウ及びゴバイシからなる群
から選択された1種または2種以上の生薬を含有する豚
赤痢の予防及び治療剤。 2)生薬が原末の形態である特許請求の範囲第1項に記
載の予防及び治療剤。 3)生薬が有機溶剤、水と有機溶剤との混合物または水
で抽出した生薬エキス及び/またはそれから得られた生
薬有効成分である特許請求の範囲第1項に記載の予防及
び治療剤。4)生薬が、飼料中に配合されてなる特許請
求の範囲第1項に記載の予防及び治療剤。 5)カンゾウ、オウレン、オウゴン、ヨウバイヒ、アロ
エ、ギュウタン、エンメイソウ及びゴバイシからなる群
から選択された1種または2種以上の生薬の有効量を投
与することからなる豚赤痢の予防及び治療方法。 6)生薬が原末の形態で用いられる特許請求の範囲第5
項に記載の予防及び治療方法。 7)生薬が有機溶剤、水と有機溶剤との混合物または水
で抽出した生薬エキス及び/またはそれから得られた生
薬有効成分である特許請求の範囲第5項に記載の予防及
び治療方法。 8)生薬が飼料に配合して投与される特許請求の範囲第
5項に記載の予防及び治療方法。[Scope of Claims] 1) A prophylactic and therapeutic agent for swine dysentery, which contains one or more crude drugs selected from the group consisting of licorice, orensis, scutellariae, scutellariae, aloe, gyutan, trifolium, and burdock. 2) The prophylactic and therapeutic agent according to claim 1, wherein the crude drug is in the form of bulk powder. 3) The prophylactic and therapeutic agent according to claim 1, wherein the crude drug is an organic solvent, a mixture of water and an organic solvent, a crude drug extract extracted with water, and/or a crude drug active ingredient obtained therefrom. 4) The prophylactic and therapeutic agent according to claim 1, wherein the crude drug is blended into feed. 5) A method for preventing and treating swine dysentery, which comprises administering an effective amount of one or more herbal medicines selected from the group consisting of licorice, scutellariae, scutellariae, scutellariae, aloe, staghorn, scutellariae, and scutellariae. 6) Claim 5 in which the crude drug is used in the form of bulk powder
Prevention and treatment methods described in Section. 7) The prevention and treatment method according to claim 5, wherein the herbal medicine is an organic solvent, a mixture of water and an organic solvent, a herbal medicine extract extracted with water, and/or an active herbal medicine ingredient obtained therefrom. 8) The prevention and treatment method according to claim 5, wherein the crude drug is administered by mixing it with feed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62328327A JP2599157B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for swine dysentery |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62328327A JP2599157B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for swine dysentery |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01172338A true JPH01172338A (en) | 1989-07-07 |
JP2599157B2 JP2599157B2 (en) | 1997-04-09 |
Family
ID=18208993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62328327A Expired - Lifetime JP2599157B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for swine dysentery |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2599157B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01285160A (en) * | 1988-05-12 | 1989-11-16 | Itochu Shiryo Kk | Feed for hog-raising |
WO1994003193A1 (en) * | 1992-07-31 | 1994-02-17 | Tsumura & Co. | Remedy for biotoxin type bacterial intestinal infectious diseases |
-
1987
- 1987-12-26 JP JP62328327A patent/JP2599157B2/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01285160A (en) * | 1988-05-12 | 1989-11-16 | Itochu Shiryo Kk | Feed for hog-raising |
JPH0466530B2 (en) * | 1988-05-12 | 1992-10-23 | Itochu Shiryo Kk | |
WO1994003193A1 (en) * | 1992-07-31 | 1994-02-17 | Tsumura & Co. | Remedy for biotoxin type bacterial intestinal infectious diseases |
Also Published As
Publication number | Publication date |
---|---|
JP2599157B2 (en) | 1997-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH01172341A (en) | Preventive and remedy for infectious disease of clostridium perfringens of domestic animal and domestic fowl | |
JP2599159B2 (en) | Prevention and treatment of bovine mastitis | |
Nyeem et al. | Solanum nigrum (Maku): A review of pharmacological activities and clinical effects | |
JP2603977B2 (en) | Prevention and treatment of Pasteurella haemolytica infection in livestock | |
CN104208294B (en) | It is a kind of to be used to treat Chinese medicine composition of piglet yellow-white dysentery and preparation method thereof | |
JP2535559B2 (en) | Agent for the prevention and treatment of pruritus in fish | |
Bandyopadhyay et al. | Medicinal pteridophytes: ethnopharmacological, phytochemical, and clinical attributes | |
KR20090094619A (en) | Compositions for enhancing immune, or preventing or treating bacterial enteritis or Coccidiosis | |
JP2535555B2 (en) | Agent for preventing and treating streptococcal disease in fish | |
JP2599152B2 (en) | Agent for prevention and treatment of pasturellosis in pigs | |
JP2599160B2 (en) | Preventive and therapeutic agent for staphylococcal disease in chickens | |
CN104258347A (en) | Sterilizing and inflammation-diminishing liquid for clinical laboratory | |
JPH01172333A (en) | Preventive and remedy for swine infectious diseases of streptococcus hemolyticus | |
JP2535554B2 (en) | Preventive and therapeutic agent for edwadiella infection in fish | |
JPH01172338A (en) | Preventive and remedy for swine dysentery | |
JP2535557B2 (en) | Agent for preventing and treating Vibrio alderi infection of fish | |
JP2535553B2 (en) | Agent for preventing and treating bacterial nodule disease in fish | |
JP2535558B2 (en) | Agent for prevention and treatment of fin fin disease of fish | |
JP2599163B2 (en) | Prevention and treatment of Salmonella tefimurium infection in livestock and poultry | |
CN102894200A (en) | Foodstuff additive used for enhancing sheep antibiosis and anti-virus, and preparation method thereof | |
JP2599158B2 (en) | Prevention and treatment of Campylobacter jejuni infection in livestock | |
JP2535556B2 (en) | Agent for prevention and treatment of vibrio disease in fish | |
JP2599154B2 (en) | Agent for prevention and treatment of haemophilus infection in pigs | |
CN116077584B (en) | Composition for preventing and treating porcine reproductive and respiratory syndrome and application method thereof | |
JPH01172328A (en) | Preventive and remedy for corynebacterium renale infection disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |